Moonlake Immunotherapeutics Forecast and Target Price
$47.12
Moonlake Immunotherapeutics (MLTX) Share Price Forecast
Currently 22 wall-street analysts regularly analyze the financials of Moonlake Immunotherapeutics on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Moonlake Immunotherapeutics (MLTX) have a share price target of $78. This median of share price forecast represents a 65.53% upside from the latest price of $47.12 as on 31.01.25.
Moonlake Immunotherapeutics (MLTX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Moonlake Immunotherapeutics (MLTX) share price will touch around $78 in next 12-months.
Moonlake Immunotherapeutics (MLTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Moonlake Immunotherapeutics's share price and its median forecast price. As on 31.01.25, the difference is -36.75%
Moonlake Immunotherapeutics (MLTX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Moonlake Immunotherapeutics (MLTX) Share Price : Analyst Recommendation
Based on 22 analysts tracking and researching Moonlake Immunotherapeutics (MLTX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 8 |
| Outperform | 9 | 10 | 10 |
| Hold | 3 | 3 | 4 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Moonlake Immunotherapeutics (MLTX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
₹0 US Stocks a/c Opening Fee